Roche’s 2026 Independent Medical Education Call for Grants funds accredited programs educating community neurologists on new Parkinson’s disease research, diagnostics, and therapies.
Funder: Roche
Due Dates: September 4, 2026 (Full grant proposal submission)
Funding Amounts: Up to $150,000 per award; single-year funding
Summary: Supports accredited providers in developing independent education programs for community neurologists on Parkinson’s disease advances and emerging therapies.
This opportunity, offered by Roche through its Genentech division, funds accredited U.S.-based providers to develop independent, certified medical education initiatives. The focus is on bridging educational gaps in the application of recent neuroscience advances—particularly those related to alpha-synuclein and biomarker tools—in the diagnosis and management of Parkinson’s disease. The grant aims to empower community neurologists to integrate emerging diagnostic modalities and therapies into clinical practice, improving patient outcomes through evidence-based education.